Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease
Cell · 2025-12 · 188 (25) · 7036-7048.e11
DOI: 10.1016/j.cell.2025.09.010 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Cell, 2025-12. Verfasst von Jin Woo Chang und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Parkinson Disease, Dopaminergic Neurons, Human Embryonic Stem Cells, Stem Cell Transplantation. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Science and ICT, South Korea, Ministry of Health and Welfare.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Korea University Anam Hospital, Seoul 02841, Republic of Korea.
- Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Neurosurgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea.
- Department of Neurology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
- Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea; S. Biomedics Co., Ltd., Seoul 04797, Republic of Korea.
- Department of Physiology, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
Förderung
- National Research Foundation of Korea
- Ministry of Science and ICT, South Korea
- Ministry of Health and Welfare
Zitieren
APA
Chang, J. W., Na, H. K., Chang, K. W., Park, C. W., Kim, D. H., Park, S., Park, C. Y., Eom, J. H., Nam, S. T., Jo, K. S., Jo, M. Y., Choi, S. K., Hur, H. J., Kim, S., Kim, M., Kim, D. S., Hwang, D. Y., Kim, M. S., Jung, I., …, & Kim, D. W. (2025). Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease. Cell, 188(25), 7036-7048.e11. https://doi.org/10.1016/j.cell.2025.09.010
Vancouver
Chang JW, Na HK, Chang KW, Park CW, Kim DH, Park S, et al. Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease. Cell. 2025;188(25):7036-7048.e11. doi:10.1016/j.cell.2025.09.010
BibTeX
@article{Chang2025,
author = {Chang, Jin Woo and Na, Han Kyu and Chang, Kyung Won and Park, Chan Wook and Kim, Do-Hun and Park, Sanghyun and Park, Chul-Yong and Eom, Jang Hyeon and Nam, Seung Taek and Jo, Ki-Sang and Jo, Mi-Young and Choi, Sung Kyoung and Hur, Hye-Jin and Kim, Sarang and Kim, Minseok and Kim, Dae-Sung and Hwang, Dong-Youn and Kim, Myoung Soo and Jung, Inkyung and Kim, Jongwan and Cho, Myung Soo and Lee, Phil Hyu and Kim, Dong-Wook},
title = {Phase 1/2a clinical trial of hESC-derived dopamine progenitors in Parkinson’s disease},
journal = {Cell},
year = {2025},
volume = {188},
number = {25},
pages = {7036--7048.e11},
doi = {10.1016/j.cell.2025.09.010}
}
EUVIMED